stockrowAdaptive Biotechnologies Corporation
ADPT Healthcare Diagnostics & Research
Adaptive Biotechnologies Corporation’s revenue for fiscal 2025 (year ended December 2025) was $277.0 million, up 54.8% from fiscal 2024.
- Revenue
- −10.7%
- EPS
- −66.7%
- Free cash flow
- +201.9%
Quarter to September 2026, against a year earlier
Follow ADPT
Alert me
Adaptive Biotechnologies Corporation (ADPT) Free cash flow
Adaptive Biotechnologies Corporation's free cash flow for fiscal 2025 was −$48.9M, compared with −$343.1M in fiscal 2024. Over the twelve months to 30 September 2026 it was −$8.8M. Over the past ten years it has ranged from −$596.6M (fiscal 2023) to $194.2M (fiscal 2019); the current reading is higher than 67% of that period. Adaptive Biotechnologies Corporation ranks 35th of 49 Diagnostics & Research companies by free cash flow.
Free cash flow, annual
Embed this chart
Annual newest first
| Period | Free cash flow | Change |
|---|---|---|
| FY2025 | −$48.9M | — |
| FY2024 | −$343.1M | — |
| FY2023 | −$596.6M | — |
| FY2022 | −$479.1M | — |
| FY2021 | −$254.5M | — |
| FY2020 | −$168.5M | — |
| FY2019 | $194.2M | — |
| FY2018 | −$38.6M | — |
| FY2017 | −$37.2M | — |
Quarterly newest first
| Period | Free cash flow | Change |
|---|---|---|
| Sep 2026 | $7.7M | — |
| Jun 2026 | −$7.6M | — |
| Mar 2026 | −$10.3M | — |
| Dec 2025 | $1.4M | — |
| 31 more quarters | Free account |
Against its own ten years
Free cash flow against peers
| Company | Free cash flow |
|---|---|
| VCYT Veracyte, Inc. compare | $161.9M |
| SHC Sotera Health Company compare | $135.4M |
| RDNT RadNet, Inc. compare | $74.4M |
| CDNA CareDx, Inc. compare | $59.8M |
| BLLN BillionToOne, Inc. compare | $33.9M |
| ADPT Adaptive Biotechnologies Corporation | −$8.8M |
| NEO NeoGenomics, Inc. compare | −$26.5M |
| WGS GeneDx Holdings Corp. compare | −$75.8M |
| GRAL GRAIL, Inc. compare | −$312.0M |
What Free cash flow is
Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.
Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)
More on ADPT
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement